Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differential gene expression in auristatin PHE-treated Cryptococcus neoformans.

Tanja Woyke1, Michael E Berens, Dominique B Hoelzinger

  • 1Cancer Research Institute, Arizona State University, Tempe, Arizona 85287, USA.

Antimicrobial Agents and Chemotherapy
|January 27, 2004
PubMed
Summary

Auristatin PHE disrupts cell division in Cryptococcus neoformans. This study used mRNA differential display to identify 29 altered transcripts, revealing new drug targets and mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Siderophore production by the lichen fungus Xanthoria parietina supports its algal symbiont.

Nature communications·2026
Same author

RAGE Inhibition Reduces Surgery-Induced Cerebral Edema After Glioma Resection.

Neurosurgery·2026
Same author

Arsenic Trioxide and the MNK1 Inhibitor AUM001 Exert Synergistic Anti-Glioblastoma Effects by Modulating Key Translational, Cell Cycle, and Transmembrane Transport Pathways.

Brain sciences·2026
Same author

Comparative evaluation of recombinant thrombin and fibrin hydrogel systems for extracellular vesicle delivery.

Biomaterials science·2025
Same author

Identifying and exploiting combinatorial synthetic lethality by characterizing adaptive kinome rewiring of EGFRvIII-driven glioblastoma.

Acta neuropathologica communications·2025
Same author

Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models.

Journal of translational medicine·2025

Area of Science:

  • Mycology
  • Molecular Biology
  • Antifungal Drug Discovery

Background:

  • The opportunistic fungal pathogen Cryptococcus neoformans poses significant health risks.
  • Auristatin PHE, an antifungal pentapeptide, is known to disrupt microtubule dynamics and cell division.
  • Understanding the broader cellular response to auristatin PHE is crucial for developing new antifungal strategies.

Purpose of the Study:

  • To comprehensively investigate the cellular response of Cryptococcus neoformans to auristatin PHE treatment.
  • To identify differentially expressed genes and pathways affected by auristatin PHE using transcriptomic analysis.
  • To provide insights into the mechanism of action and selectivity of auristatin PHE.

Main Methods:

  • Utilized mRNA differential display (DD) to screen for gene expression changes.

Related Experiment Videos

  • Employed reverse transcriptase PCR (RT-PCR) for validation of differentially expressed transcripts.
  • Analyzed approximately 60% of the cell transcriptome in auristatin PHE-treated C. neoformans.

    • Main Results:

    • Identified 29 transcript expression differences between control and auristatin PHE-treated C. neoformans populations.
    • Confirmed differential expression of 14 transcripts using RT-PCR.
    • Observed modulation of genes involved in cell cycle regulation (e.g., RHO1), transport (e.g., Afr1p), and stress response (e.g., HSP104 homolog).
    • Discovered three responsive transcripts of unknown function.

    Conclusions:

    • Auristatin PHE significantly alters gene expression in C. neoformans, impacting key cellular processes.
    • The identified differentially expressed genes offer potential targets for understanding auristatin PHE's mechanism and selectivity.
    • This study represents the first application of DD for analyzing drug action in C. neoformans, opening avenues for future research.